ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Celldex Therapeutics
The Manager, Expanded Access Program oversees the global EAP portfolio, ensuring vendor performance, regulatory compliance, and seamless access to investigational products for physicians and patients. Reporting to the Executive Director of Clinical Operations, the role coordinates cross‑functional teams and external service providers to manage requests efficiently and safely.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
34% above the average for this role
Site Management, Lead
myTomorrows
Director, Managed Access Regulatory Strategy
lifelancer
Director of EAP Operations (Expanded Access Programs and Site Management)
myTomorrows
Director, Managed Access Regulatory Strategy
lifelancer
Director, Managed Access Regulatory Strategy
lifelancer
EAP Program Manager - US
Hickey's Pharmacy